Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Net Margin (2019 - 2025)

Historic Net Margin for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 64.91%.

  • Pulmonx's Net Margin rose 45100.0% to 64.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.9%, marking a year-over-year increase of 101600.0%. This contributed to the annual value of 67.3% for FY2024, which is 212900.0% up from last year.
  • As of Q3 2025, Pulmonx's Net Margin stood at 64.91%, which was up 45100.0% from 63.69% recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Net Margin ranged from a high of 55.28% in Q4 2024 and a low of 147.07% during Q1 2022
  • Over the past 5 years, Pulmonx's median Net Margin value was 84.57% (recorded in 2023), while the average stood at 88.81%.
  • The largest annual percentage gain for Pulmonx's Net Margin in the last 5 years was 2191000bps (2021), contrasted with its biggest fall of -525900bps (2021).
  • Over the past 5 years, Pulmonx's Net Margin (Quarter) stood at 94.81% in 2021, then increased by 2bps to 92.6% in 2022, then rose by 22bps to 72.04% in 2023, then rose by 23bps to 55.28% in 2024, then decreased by -17bps to 64.91% in 2025.
  • Its Net Margin was 64.91% in Q3 2025, compared to 63.69% in Q2 2025 and 64.11% in Q1 2025.